Article Details

FDA to Review Barth Syndrome Treatment Elamipretide - eMPR.com

Retrieved on: 2024-04-08 23:12:55

Tags for this article:

Click the tags to see associated articles and topics

FDA to Review Barth Syndrome Treatment Elamipretide - eMPR.com. View article details on hiswai:

Excerpt

AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful · March 13, 2024 ; Increase in Percentage of OD Deaths From 2020 to 2022 Involving ...

Article found on: www.empr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo